Your browser doesn't support javascript.
loading
In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine.
Muthumani, Karuppiah; Griffin, Bryan D; Agarwal, Sangya; Kudchodkar, Sagar B; Reuschel, Emma L; Choi, Hyeree; Kraynyak, Kimberly A; Duperret, Elizabeth K; Keaton, Amelia Anne; Chung, Christopher; Kim, Yinho K; Booth, Stephanie A; Racine, Trina; Yan, Jian; Morrow, Matthew P; Jiang, Jingjing; Lee, Brian; Ramos, Stephanie; Broderick, Kate E; Reed, Charles C; Khan, Amir S; Humeau, Laurent; Ugen, Kenneth E; Park, Young K; Maslow, Joel N; Sardesai, Niranjan Y; Joseph Kim, J; Kobinger, Gary P; Weiner, David B.
Afiliação
  • Muthumani K; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, USA.
  • Griffin BD; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada R3E 3R2.
  • Agarwal S; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0J9.
  • Kudchodkar SB; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, USA.
  • Reuschel EL; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, USA.
  • Choi H; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, USA.
  • Kraynyak KA; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, USA.
  • Duperret EK; Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
  • Keaton AA; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, USA.
  • Chung C; Division of Infectious Diseases, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Kim YK; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, USA.
  • Booth SA; The Wistar Institute, 3601 Spruce Street, Philadelphia, PA, USA.
  • Racine T; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada R3E 3R2.
  • Yan J; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0J9.
  • Morrow MP; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada R3E 3R2.
  • Jiang J; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0J9.
  • Lee B; Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
  • Ramos S; Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
  • Broderick KE; Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
  • Reed CC; Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
  • Khan AS; Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
  • Humeau L; Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
  • Ugen KE; Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
  • Park YK; Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
  • Maslow JN; Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
  • Sardesai NY; Department of Molecular Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
  • Joseph Kim J; GeneOne Life Science Inc., Teheran-Ro, Gangnam-Gu, Seoul, Korea.
  • Kobinger GP; GeneOne Life Science Inc., Teheran-Ro, Gangnam-Gu, Seoul, Korea.
  • Weiner DB; Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
NPJ Vaccines ; 1: 16021, 2016.
Article em En | MEDLINE | ID: mdl-29263859
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies Idioma: En Revista: NPJ Vaccines Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies Idioma: En Revista: NPJ Vaccines Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido